NL-OMON50564已完成不适用
Multicenter study of the performance of Fabian-PRICO for saturation targeting routine use in the NICU - PRICO performance in the NIC
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 13
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 0 至 0（—）
入选标准
- •Infants with respiratory insufficiency admitted to the NICU who require
- •respiratory support and supplemental oxygen (FiO2 > 0.21) in one of 4
- •therapeutic categories (HFOV , CMV, Non-Invasive nasal mask, nasal cannula).
- •Informed Consent Form obtained as per EC requirement.
排除标准
- •Not expected to complete 48 hours of the current respiratory support
- •therapeutic category
- •Congenital anomalies
- •Uncontrolled hemodynamics instability
- •Severe airflow obstruction
- •Intracranial hypertension
- •Start of caffeine therapy within 12 hours of entering the study protocol
- •Attending physician does not believe participation of the patient is in their
- •best interest.
研究者
相似试验
进行中（未招募）
不适用
A multicenter Study Evaluating the Efficacy of Nifedipine GITS ? Telmisartan Combination in Blood Pressure Control and Beyond: comparison of two strategies. - TALENTMedDRA version: 6.1Level: PTClassification code 10020772HypertensionEUCTR2006-006436-22-ITBAYER400
进行中（未招募）
1 期
A study evaluating the safety and efficacy of 19CP02 in subjects with non-Hodgkin lymphomaRelapsed/refractory B-cell non-Hodgkin lymphomaMedDRA version: 20.0Level: HLGTClassification code 10025320Term: Lymphomas non-Hodgkin's B-cellSystem Organ Class: 10005329 - Blood and lymphatic system disordersEUCTR2021-003272-13-NLCellPoint B.V.45
进行中（未招募）
1 期
A study evaluating the safety and efficacy of 19CP02 in subjects with non-Hodgkin lymphomaEUCTR2021-003272-13-BECellPoint B.V.45
进行中（未招募）
1 期
A study evaluating the safety and efficacy of GLPG5101 (19CP02) in subjects with non-Hodgkin lymphomaCTIS2022-502661-23-00Galapagos40
招募中
不适用
A phase I/II, multicenter study evaluating the feasibility, safety, and efficacy of point-of-care manufactured 19CP02 in subjects with relapsed/refractory B-cell non-Hodgkin lymphomacancer of the lymphatic system10025320LymphomaNL-OMON51902CellPoint B.V.15